Stock Price Quote

AAREY DRUGS & PHARMACEUTICALS LTD.

NSE : AAREYDRUGSBSE : 524412ISIN CODE : INE198H01019Industry : Pharmaceuticals & DrugsHouse : Aarey
BSE47.000 (0 %)
PREV CLOSE ( ) 47.00
OPEN PRICE ( ) 45.01
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2183
TODAY'S LOW / HIGH ( )45.01 47.40
52 WK LOW / HIGH ( )26.82 68
NSE47.100.5 (+1.07 %)
PREV CLOSE( ) 46.60
OPEN PRICE ( ) 47.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14112
TODAY'S LOW / HIGH( ) 46.50 48.00
52 WK LOW / HIGH ( )27 68
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-05 1990
Management Info
Mihir R Ghatalia - Chairman Mihir R Ghatalia - Managing Director
Registered Office

Address E 34,M I D C ,Tarapur Boisar,
Thane,
Maharashtra-401506

Phone 022-23455543

Email info@aareydrugs.com

Website www.aareydrugs.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

12Apr Aarey Drugs and Pharmaceuticals infor
Aarey Drugs and Pharmaceuticals has informed that there is no deviation..
27Mar Allotment of Convertible warrants
Inter alia, approved: 1. Allotted 2669619 (Twenty Six Lakhs Sixty nine..
27Mar Allotment of Equity Shares
Inter alia, approved: 1. Allotted 2669619 (Twenty Six Lakhs Sixty nine..
20Mar Allotment of Convertible warrants
Inter alia, to consider the allotment of Equity Shares and Warrants
20Mar Allotment of Equity Shares
Inter alia, to consider the allotment of Equity Shares and Warrants

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit19.070000000000137.7699999999997
Gross Profit 14.6400000000002 60.1599999999997
Operating Profit 29.9600000000002104.57
Net Sales 764.764142.53

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE)
peergroup  1455.20 (10.00%)
M.Cap ( in Cr)846.88
Solara Active Pharma (BSE)
peergroup  551.45 (16.32%)
M.Cap ( in Cr)1985.01
Abbott India (BSE)
peergroup  26131.85 (0.29%)
M.Cap ( in Cr)55528.36
Windlas Biotech (BSE)
peergroup  555.05 (6.97%)
M.Cap ( in Cr)1154.42
Concord Biotech (BSE)
peergroup  1595.25 (1.05%)
M.Cap ( in Cr)16688.90

Shareholding Pattern

NON-INSTITUTION 51.32%
PROMOTERS 45.28%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Aarey Drugs & Pharmaceuticals Ltd.

Aarey Drugs & Pharmaceuticals Ltd. was incorporated in the year 1990. Its today's share price is 47. Its current market capitalisation stands at Rs 131.86 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4189.56 Cr and Total Income of Rs.4216.86 Cr. The company's management includes Bina Ghatalia, Nimit R Ghatalia, Preeti Paresh Rathi, Anil Mandal, Lalit R Tulsiani, Chetan Kiritbhai Mehta, Mihir R Ghatalia, Mihir R Ghatalia.

It is listed on the BSE with a BSE Code of 524412 , NSE with an NSE Symbol of AAREYDRUGS and ISIN of INE198H01019. It's Registered office is at E 34,M I D C ,Tarapur BoisarThane-401506, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are DMKH & Co, Motilal & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.